Stay updated on Filgotinib Efficacy in Perianal Fistulizing Crohn's Disease Clinical Trial
Sign up to get notified when there's something new on the Filgotinib Efficacy in Perianal Fistulizing Crohn's Disease Clinical Trial page.

Latest updates to the Filgotinib Efficacy in Perianal Fistulizing Crohn's Disease Clinical Trial page
- Check2 days agoChange DetectedThe page footer now shows Revision: v3.5.5, replacing the previous v3.5.4, signaling a small maintenance or content refresh of the page.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedLakefront Biotherapeutics NV was added as a collaborator for the study, indicating a new partner organization involved in the trial's governance and coordination. Galapagos NV was removed as a collaborator, reflecting a change in the study's partnership landscape.SummaryDifference0.0%

- Check23 days agoChange DetectedA new site revision tag (v3.5.4) was added, replacing the previous revision tag (v3.5.3). This indicates an update to the page's template or content management without altering the study details.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page’s release/version indicator was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2, adding Revision: v3.5.2 and removing Revision: v3.5.0.SummaryDifference0.0%

- Check80 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0 in the page footer.SummaryDifference0.0%

Stay in the know with updates to Filgotinib Efficacy in Perianal Fistulizing Crohn's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Filgotinib Efficacy in Perianal Fistulizing Crohn's Disease Clinical Trial page.